Lilly Oncology Medical(@LillyOncMed):🔬 FRAmework-01 | Now Enrolling A phase 3 trial evaluating a FRα-targeting ADC in patients with Ovarian Cancer. Key details: - Enrolling PSOC and PROC - All FRα expression levels - Allows prior mirvetuximab Click the image for trial & enrollment info

Lilly Oncology Medical

@LillyOncMed

Dedicated to communicating the latest science & disease state education from Lilly Oncology. Intended for U.S. HCPs. Community Guidelines:

参加 March 2022

599 フォロー中 6.5K ファン

Lilly Oncology Medical@LillyOncMed

2026.05.04 14:12

🔬 FRAmework-01 | Now Enrolling A phase 3 trial evaluating a FRα-targeting ADC in patients with Ovarian Cancer. Key details: - Enrolling PSOC and PROC - All FRα expression levels - Allows prior mirvetuximab Click the image for trial & enrollment info